COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAHPRA TV
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK TO SAHPRA
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAHPRA TV
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK TO SAHPRA
October 2019
Press Releases
SAHPRA FINAL MEDIA RELEASE UPDATE ON RANITIDINE CONTAINING MEDICINES
October 29, 2019
Press Releases
CANNABIS AND RELATED SUBSTANCES
October 25, 2019
Safety Alerts
MSA promethazine
October 25, 2019
Safety Alerts
Uncategorized
MSA ketoconazole and domperidone
October 25, 2019
Safety Alerts
MSA gamma benzine hexachloride
October 25, 2019
Safety Alerts
MSA cough and cold medicines
October 25, 2019
Safety Alerts
MSA atypical antipsychotics
October 25, 2019
Safety Alerts
DHCPL for ACE-inhibitor/Angiotensin receptor blocker containing medicines
October 25, 2019
Presentations
The Status of Cannabis for Medicinal and Research Purposes
October 25, 2019
Presentations
SAHPRA – APP – PRESENTATION TO PORTFOLIO COMMITTEE
October 25, 2019
1
2
3
